BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36990315)

  • 1. Doping with testosterone and androgenic/anabolic steroids: Impact on health, screening tools and medical care.
    Young J
    Ann Endocrinol (Paris); 2023 May; 84(3):401-405. PubMed ID: 36990315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
    Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
    Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anabolic and androgenic steroids and/or their esters in horse hair using ultra-high performance liquid chromatography-high resolution mass spectrometry.
    Kwok KY; Choi TLS; Kwok WH; Wong JKY; Wan TSM
    J Chromatogr A; 2017 Apr; 1493():76-86. PubMed ID: 28314523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes.
    Ponzetto F; Parasiliti-Caprino M; Gesmundo I; Marinelli L; Nonnato A; Nicoli R; Kuuranne T; Mengozzi G; Ghigo E; Settanni F
    Talanta; 2023 Apr; 255():124218. PubMed ID: 36603442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous steroid profiling in the athlete biological passport.
    Sottas PE; Saugy M; Saudan C
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):59-73, viii-ix. PubMed ID: 20122450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
    Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
    Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRMS delta values (
    Brailsford AD; Majidin WNM; Wojek N; Cowan DA; Walker C
    Drug Test Anal; 2018 Nov; 10(11-12):1722-1727. PubMed ID: 30381908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use, Misuse and Abuse of Testosterone and Other Androgens.
    Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
    Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of endocrinologists managing recovery from anabolic androgenic steroid induced hypogonadism.
    Grant B; Pradeep A; Minhas S; Dhillo WS; Quinton R; Jayasena CN
    Reprod Fertil; 2023 Jan; 4(1):. PubMed ID: 36757334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doping and sports endocrinology: anabolic-androgenic steroids.
    García-Arnés JA; García-Casares N
    Rev Clin Esp (Barc); 2022 Dec; 222(10):612-620. PubMed ID: 36400345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Profiling of Endogenous Steroids in Blood Using the Athlete Biological Passport Approach.
    Equey T; Salamin O; Ponzetto F; Nicoli R; Kuuranne T; Saugy J; Saugy M; Aikin R; Baume N
    J Clin Endocrinol Metab; 2023 Jul; 108(8):1937-1946. PubMed ID: 36794909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Management of Anabolic Androgenic Steroid Use.
    Anawalt BD
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of androgenic-anabolic steroids in athletes.
    Hartgens F; Kuipers H
    Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgenic Steroids Use and Abuse: Past, Present, and Future.
    Thirumalai A; Anawalt BD
    Urol Clin North Am; 2022 Nov; 49(4):645-663. PubMed ID: 36309421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Proteins As Markers for Anabolic Steroid Abuse: A New Perspective in Doping Control?
    Sansoucy M; Naud JF
    Chem Res Toxicol; 2023 Aug; 36(8):1168-1173. PubMed ID: 37561919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabling the inclusion of non-hydrolysed sulfated long term anabolic steroid metabolites in a screening for doping substances by means of gas chromatography quadrupole time-of-flight mass spectrometry.
    Albertsdóttir AD; Van Gansbeke W; Van Eenoo P; Polet M
    J Chromatogr A; 2021 Apr; 1642():462039. PubMed ID: 33735641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone and doping control.
    Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.